Coverage
Filings
| Filing | Date |
|---|---|
| Information on the AGM of Orion Corporat | 23 Mar 2004 |
| Erkki Etola elected Vice Chairman of Ori | 23 Mar 2004 |
| Orion Group 2003 Financial Statements | 13 Feb 2004 |
| PROPOSALS BY THE BOARD OF DIRECTORS TO T | 13 Feb 2004 |
| 16,800 Orion A-shares converted into B-s | 12 Feb 2004 |
| 35,000 Orion A-shares converted into B-s | 6 Feb 2004 |
| Orion distributes an additional dividend | 11 Dec 2003 |
| Risto Kanerva appointed new President of | 8 Dec 2003 |
Orion's collaboration partner Bayer announced U.S. FDA approval for darolutamide, an androgen receptor inhibitor (ARi), for metastatic hormone-sensitive prostate cancer (mHSPC).
| 110,000 Orion A-shares converted into B- | 2 Dec 2003 |
| Additional dividend of EUR 1.50 proposed | 20 Nov 2003 |
| Orion Group Interim Report 1-9/2003 | 5 Nov 2003 |
| EU approval granted for Stalevo, Orion's | 23 Oct 2003 |